o Source: PubMed 3. Study: "Mesenchymal Stem Cells for Treatment of Tendon and Ligament Injuries-clinical Evidence" (2020)
o Findings: MSCs accelerate recovery from ligament, tendon, and muscle injuries, enhancing tissue repair.
Source: PubMed
o
Metabolic Disorders 1. Study: "Therapeutic potential of MSCs in treating metabolic syndrome and related disorders." o Findings: MSCs reduce inflammation, improve insulin sensitivity, and ameliorate metabolic abnormalities.
Source: Oxford Academic
o
Type II Diabetes 1. Study: "Advances and challenges of the cell-based therapies among diabetic patients" (2024) o Findings: MSCs regenerate pancreatic beta cells, improving insulin secretion and glucose tolerance. o Source: Diabetes Care Journal 2. Study: "Stem Cell Therapy in Treating Diabetic Complications" (2018) o Findings: MSC therapy reduces insulin resistance, systemic inflammation, and improves glycemic control in diabetic patients. o Source: Diabetes Care Journal 3. Study: "Stem Cell Therapy: Success and Continuing Progress in Treating Diabetes" (2018) o Findings: Adipose-derived MSCs significantly lower HbA1c levels and reduce insulin requirements, showing promise in managing diabetes.
o Source: Clin Med International Library
© 2024 Longevity Medical Institute. All rights reserved.
15
Made with FlippingBook Annual report maker